Due to the risk of congestive heart failure, the FDA is requiring that the type 2 diabetes drug Avandia be labeled with a black box warning detailing the risks.
FDA Requires Black Box Warning for Avandia
October 16, 2015 by
Contact us 855-906-3750
Due to the risk of congestive heart failure, the FDA is requiring that the type 2 diabetes drug Avandia be labeled with a black box warning detailing the risks.
Home | About the firm | Practice areas | Online resources | Contact us | News and Events | Espanol
Copyright © 2018 By Bailey & Galyen. All Rights Reserved. Disclaimer | Sitemap
Concept, Design and Hosting by GetLegal Web Development Team.